Reshentha Beeby, 10% Owner, Director at Acer Therapeutics Inc. (ACER), bought 275,000 shares at $18.00 ($5.0M) on 2018-08-01, disclosed to the SEC on 2018-08-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.